- Pfizer Inc (PFE) Q1 2019 Earnings Call Transcript Motley Fool
- Pfizer Earnings Top Estimates as New CEO Bourla Takes Reins Bloomberg
- Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Yahoo Finance
- Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript Seeking Alpha
- Pfizer 1Q profit jumps 9% on higher drug sales, lower costs KIRO Seattle
- View full coverage on Google News
Pfizer: Added Value For A Defensive Pharma Portfolio Seeking Alpha
- What You Must Know About Pfizer Inc.?s (NYSE:PFE) Financial Strength Simply Wall St
- Pfizer Inc. (PFE) Holdings Cut by Neumann Capital Management LLC Mayfield Recorder
- Pendal Group Ltd Raises Holdings in Pfizer Inc. (NYSE:PFE) Tech Know Bits
- Igniting Curiosity on This Name, Investor Update on Pfizer Inc. (NYSE:PFE) Hermann Herald
- P2 Capital Partners Holds Holding in Brinks Co (BCO); Pfizer (PFE) Holder Bowling Portfolio Management Trimmed Its Stake The NBO News
- View full coverage on Google News
Of the 6 largest pharmaceutical companies by market cap, Pfizer is the most balanced and with the shallowest patent cliff. Its best selling drugs are immune to.
PFIZER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Pfizer Inc. - PFE Yahoo Finance
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (?KSF?), announces that KSF has commenced ...
Pfizer: A 3.5% Yield, But Lyrica's Patent Loss Keeps Me From Buying Seeking Alpha
Pfizer Inc. is a global biopharma giant with a 3.5% dividend yield and a broad portfolio of therapies and consumer healthcare products. Pfizer has invested in R.
Where Will Pfizer Be in 5 Years? Motley Fool
The last five years were good for Pfizer shareholders. Here's how the next five could be different.
Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019 Seeking Alpha
Pfizer announced that it had achieved positive top-line results from its phase 3 study using abrocitinb to treat patients with atopic dermatitis (eczema). Top-l.
Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is Achieved Seeking Alpha
Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...
Better Buy: AbbVie vs. Pfizer Yahoo Finance
AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?
Pfizer Announces Top-Line Results from Phase 3 Trial of LYRICA® (pregabalin) in Primary Generalized Tonic-Clonic Seizures Yahoo Finance
Pfizer Inc. (PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of ...
Better Buy: Eli Lilly vs. Pfizer The Motley Fool
If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE:LLY) and Pfizer (NYSE:PFE) are naturally two top candidates. Both big drugmakers ...
Pfizer Acquires Therachon, Looks To Add To Rare Disease Pipeline Seeking Alpha
Pfizer acquires private biotech Therachon to gain a clinical product, known as TA-46, to treat patients with Achondroplasia. Pfizer paid an upfront payment of $
Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth Forbes
Pfizer (NYSE:PFE) recently reported its Q1 2019 results, which were above our estimates. This note details the company's Q1 performance, and Trefis' forecast ...
Pfizer?s Pipeline Makes Progress as Sales Grow The Wall Street Journal
Pfizer's new portfolio of prescription drugs lifted sales during the first quarter as the company said it continues to make progress on growing through its internal ...
Can Pfizer Leap Over the Competition With This Potential Blockbuster? Yahoo Finance
The Food and Drug Administration (FDA) often sends new drug applications back to pharmaceutical companies with requests for more evidence. Recently ...
Pfizer Stock: Is It A Buy Right Now? Here's What Earnings, PFE Chart Show Investor's Business Daily
Pfizer stock has fallen harder than other drug makers this year. News has been upbeat with a drug approval and earnings beat. Is Pfizer a buy right now?
Pfizer Denies Encouraging Drug Abuse By Packaging Fentanyl With Cooking Spoon, Lighter The Onion
NEW YORK?In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer released a ...
FDA OKs expanded use of Pfizer's anticoagulant Fragmin Seeking Alpha
The FDA has approved Pfizer's (PFE +1.2%) Fragmin (dalteparin sodium) injection to reduce the recurrence of symptomatic venous thromboembolism (VTE) in ...
Teva, Pfizer, Sandoz among 20 companies accused of illegally hiking generic drug prices NorthJersey.com
Federal authorities say 20 companies, including Teva, Sandoz and Pfizer, illegally conspired to hike generic drug prices.
Insurers Brace For Pfizer's $225K Heart Drug And Whether To Pay For It Forbes
It's unclear whether health insurers and PBMs will cover Pfizer's $225000 a year drug tafamidis to treat a rare heart disease.
Google sister-company Verily is teaming with big pharma on clinical trials CNBC
Verily, Alphabet's health and life sciences division, is moving into the clinical trials market. It just announced strategic alliances with Novartis, Sanofi, Otsuka and ...
Pfizer gets U.S. approval for $225,000 a year heart drug Reuters
NEW YORK (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer Inc's oral drug, tafamidis, to treat a rare and fatal heart disease ...
5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term The Motley Fool
A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.
Pfizer Lifts 2019 Earnings Forecast as Biopharma Sales Drive Q1 Profit Beat TheStreet.com
Pfizer posted stronger-than-expected first quarter earnings Tuesday, and boosted the mid-point of its full-year profit forecast thanks to anticipated gains in ...
Better Buy: Pfizer vs. AbbVie The Motley Fool
Which big pharma stock is more likely to be the bigger winner over the long run?
Pfizer Gains After Being Named 'Top Pick' by Credit Suisse TheStreet.com
Shares of Pfizer (PFE - Get Report) posted gains on Thursday after the drugmaker was named a "top pick" at Credit Suisse following a meeting the analysts had ...
Pfizer And Others Join Working Group To Use Blockchain Protocol For Supply Chain Management Forbes
Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have all joined the MediLedger Project Contracting and Chargebacks ...
Eli Lilly, Merck, and Pfizer Earnings Are Coming. Here?s What to Watch. Barron's
The three big pharmaceutical companies ? Eli Lilly, Merck, and Pfizer ? are due to release their results on Tuesday. Although health care had a fairly good ...
Commit To Buy Pfizer At $30, Earn 4.3% Using Options Nasdaq
Investors considering a purchase of Pfizer Inc (Symbol: PFE) stock, but cautious about paying the going market price of $40.60/share, might benefit.
Sarepta: Buy The Pfizer Selloff Seeking Alpha
Pfizer's upcoming data reveal created a perfect sell the news event for Sarepta. The road to DMD drug greatness is strewn with failures as Pfizer has a lot to p.
Pfizer to buy Therachon for $340M, taking on BioMarin, Ascendis BioPharma Dive
Pfizer will pay $340 million upfront to acquire a private biotech, taking over development of an experimental dwarfism therapy that will pit the giant drugmaker ...
Top vaccine makers Merck and Pfizer target China and older adults next CNBC
Four giant companies now dominate global vaccine sales. With newer and more expensive vaccines becoming available, the market value of vaccines could ...
Pfizer touts late-stage win for JAK drug that could duel with Dupixent BioPharma Dive
Pfizer said Wednesday its experimental JAK1 inhibitor succeeded in a pivotal eczema study, although safety questions remain largely unanswered in a sparse ...
Top Stock Reports for Pfizer, Intel & HCA Healthcare Yahoo Finance
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, ...
Pfizer profit jumps 9% on higher sales, lower costs Champaign/Urbana News-Gazette
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit ...
Merck, Pfizer Stock Rise, Lilly Slips as Big Pharma Earnings Roll In Barron's
Both Merck stock and Pfizer stock are were on the rise Tuesday morning after reporting first-quarter earnings, while Eli Lilly stock slipped into the red following ...
Here are the biggest analyst calls of the day: Macy's, Pfizer, Owens Corning & more Yahoo Finance
Here are the biggest calls on Wall Street on Thursday: Goldman Sachs upgraded Macy's to 'neutral' from 'sell'. Goldman said the underperformance of the stock ...
Pfizer Earnings, Merck Earnings Top; Eli Lilly Falls On Revenue Investor's Business Daily
Pfizer earnings and Merck earnings beat, with the Dow drug giants giving decent outlooks. Pfizer stock, Merck stock rose. Eli Lilly stock fell on revenue.
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock Investorplace.com
Buy Pfizer stock on this current round of weakness. As Credit Suisse knows, the underpinnings are bullish for 2020 and beyond.
The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer Yahoo Finance
For Immediate Release. Chicago, IL ?May 15, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...
Pfizer jumps into the heated PhIII race for new-wave JAK inhibitors ? but safety frets loom large Endpoints News
Pfizer has racked up a positive slate of Phase III data for its anti-?inflammatory JAK1 inhibitor abrocitinib (PF-?04965842), which the pharma giant is hoping to ...
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for May 09, 2019 Nasdaq
Pfizer, Inc. ( PFE ) will begin trading ex-dividend on May 09, 2019. A cash dividend payment of $0.36 per share is scheduled to be paid on June 07,.
Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs Zacks.com
FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs.
Pfizer, other pharma companies join blockchain project Becker's Hospital Review
To reduce costs, errors and inefficiencies, Pfizer and other pharmaceutical companies have joined a blockchain project led by technology company Chronicled, ...
Canavan Disease Therapeutics Swot Analysis Of Leading Key Players | Pfizer Inc Turing Pharmaceuticals AG Thefeedgraph
Home · Canavan Disease Therapeutics Swot Analysis Of Leading Key Players | Pfizer IncTuring Pharmaceuticals AG? May 26, 2019 Researchunt General ...
Pfizer prospects for tafamidis market BioPharma Dive
Pfizer expects the Food and Drug Administration to decide in July on approval of tafamidis in the rare disease transthyretin amyloid cardiomyopathy. Assuming ...
Pfizer unveils new manufacturing facility | News Andover Townsman
A ribbon-cutting ceremony held last Thursday morning celebrated Pfizer's new 175000-square-foot clinical manufacturing facility at the company's campus on ...
Risk-Based Monitoring: Pfizer and BMS Seek Clarity on FDA Draft Guidance Regulatory Focus
Pfizer and Bristol-Myers Squibb (BMS) recently raised questions with and sought further clarity from the US Food and Drug Administration (FDA) on a draft ...
Why Income Investors Should Have Pfizer Inc. (NYSE:PFE) In Their Portfolio Simply Wall St
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Over the past 10 years Pfizer Inc.
Pfizer's Eczema Candidate Meets All Goals in Phase III Study Yahoo Finance
Pfizer's (PFE) investigational eczema treatment abrocitinib succeeds in pivotal late-stage study.
Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & more CNBC
Check out the companies making headlines before the bell: Walmart ? The retail giant reported adjusted quarterly profit of $1.13 per share, 11 cents a share ...
Brainstorm Health: Royal Baby, All of Us, Pfizer Heart Drug Approval Fortune
Happy Monday, readers. I hope you've had a wonderful weekend. Alright, I'll come clean up top? This sort of is about the royal baby. But only as a point of ...
Healthcare Transformer 2019: Lidia Fonseca, Pfizer - Top 40 Transformers - MM&M Medical Marketing and Media
You might say Lidia Fonseca has been solving problems since she was a little girl. Born in Mexico, Fonseca moved to the U.S. when she was 10. ?I learned to ...
Next level of support for Pioneer? Pfizer or J&J? The viewers #AskHalftime Yahoo Finance
The "Halftime Report" traders answer viewer questions on Pioneer, Pfizer, J&J, FedEx and Foot Locker.
New Jersey Better Educational Savings Trust Has Trimmed Its Stake in Pfizer (PFE) as Share Value Declined; Oxbow Advisors Continues to Hold Holding in Bristol (BMY) The EN Herald
New Jersey Better Educational Savings Trust decreased its stake in Pfizer Inc (PFE) by 29.03% based on its latest 2018Q4 regulatory filing with the SEC.
Grassi Investment Management Boosted Its Pfizer (PFE) Stake by $1.40 Million; Plante Moran Financial Advisors Continues to Hold Position in Apple (AAPL) The EN Herald
Grassi Investment Management increased its stake in Pfizer Inc (PFE) by 17.17% based on its latest 2018Q4 regulatory filing with the SEC. Grassi Investment ...
?Global Dibigatran Market 2019 ? Pfizer, Inc. (US), Bayer Healthcare AG (Germany), GlaxoSmithKline Plc. (UK) ? Journallic Journallic
The Global Dibigatran market report is a most important research for who looks for complete information on the Dibigatran market. The report covers all ...
Pfizer stock up 1.7% after earnings and revenue beat MarketWatch
Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its...
Pfizer (PFE) Valuation Declined While Wilbanks Smith & Thomas Asset Management Has Trimmed by $328,520 Its Holding; As Nvidia (NVDA) Shares Declined, Holder Bender Robert & Associates Has Trimmed Its Position by $374,661 The EN Herald
Wilbanks Smith & Thomas Asset Management Llc decreased its stake in Pfizer Inc (PFE) by 5.74% based on its latest 2018Q4 regulatory filing with the SEC.
CCI approves GSK, Pfizer consumer healthcare JV formation Livemint
CCI in a tweet confirmed about the approval of the JV.The proposed combination involves acquisition of Pfizer's consumer healthcare business by GSK.
Aqr Capital Management Increased Its Pfizer (PFE) Position by $550.12 Million; Cit Group (CIT) Position Upped by Birch Run Capital Advisors Lp The EN Herald
Aqr Capital Management Llc increased its stake in Pfizer Inc (PFE) by 88.53% based on its latest 2018Q4 regulatory filing with the SEC. Aqr Capital ...
Updated: Pfizer Calls for Compromise on Retroactively Using Suffixes in Biologic Names Regulatory Focus
In response to the US Food and Drug Administration's (FDA) proposal to not go back and rename certain biologics with nonsense suffixes, as it once said it ...
Global Nanoparticles ? Metal & Metal Oxides Market 2019 Pfizer Inc., Nanobiotix, nanoComposix, AstraZeneca, Merck KGaA News Magazine 24
The report on the Global Nanoparticles ? Metal & Metal Oxides Market offers complete data on the Nanoparticles ? Metal & Metal Oxides market. Components ...
Pfizer acquires Therachon for $350m BioPharma-Reporter.com
Pfizer will acquire Therachon to gain access to TA-46, the biotech's lead drug candidate for the treatment of achondroplasia. The deal sees Pfizer pay $370m ...
44 AGs File Antitrust Lawsuit Against Pfizer, Teva for Allegedly Fixing Prices of Generic Drugs | Connecticut Law Tribune Law.com
Connecticut is leading a 44-state coalition alleging price-fixing by 20 makers of generic drugs. Their lawsuit seeks payments of billions of dollars to these states.
Pfizer Inc. Issues A Voluntary Nationwide Consumer Level Recall of One Lot of ThermaCare® Back Pain Therapy HeatWraps, up to 16HR pain relief, Due To Out of Specification Results for High Cell Temperature FDA.gov
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public *service*. FDA does not endorse ...
Get Back into Growth Stocks Like Pfizer Inc. (PFE), Nokia Corporation (NOK) Financial Mercury
Looking at top Wall Street opinions, Pfizer Inc. (NYSE: PFE) has recently made its way into the research list of Citigroup ? signaling that their analyst's rating ...
Exact Sciences starts to see payoff from Pfizer marketing tie-up FierceBiotech
Exact Sciences has begun to reap both the benefits and drawbacks since it kicked off a sales and marketing partnership with Pfizer late last year to help promote ...
Facebook (FB) Holder Tb Alternative Assets LTD Decreased Stake by $3.63 Million as Stock Price Rose; Miles Capital Has Lowered Pfizer (PFE) Stake by $320,350 The EN Herald
Tb Alternative Assets Ltd decreased its stake in Facebook Inc (FB) by 61.01% based on its latest 2018Q4 regulatory filing with the SEC. Tb Alternative Assets ...
What Are Analysts Recommending for PFE after Q1 Results? Market Realist
On April 30, Pfizer (PFE) reported first-quarter results. The company reported revenues of $13.12 billion in the first quarter, a YoY rise of 2% on a reported basis ...
Pharma Stock Roundup: MRK, LLY, PFE Report Q1 Earnings, SNY, ABBV Drugs Get EU Nod Zacks.com
Merck (MRK), Pfizer (PFE), Lilly (LLY) announce Q1 results. European Commission grants approval to AbbVie's (ABBV) Skyrizi and Sanofi's (SNY) Zynquista.
Pfizer's alliance with Sosei Heptares bears first fruit PMLiVE
Pfizer has selected the first candidates in its four-year-old alliance with Sosei Heptares, the UK unit of Japanese biotech Sosei Group, sparking a $3m milestone ...
As Microsoft (MSFT) Shares Rose, Harvard Management Co Has Increased Stake; Pfizer (PFE) Stake Lifted by Legacy Private Trust The EN Herald
Harvard Management Co Inc increased its stake in Microsoft Corp (MSFT) by 27.96% based on its latest 2018Q4 regulatory filing with the SEC. Harvard ...
PFIZER REPORTS FIRST-QUARTER 2019 RESULTS Yahoo Finance
NEW YORK-- -- First-Quarter 2019 Revenues of $13.1 Billion, Reflecting 5% Operational Growth Driven by 7% Operational Growth from Pfizer ...
GSK-Pfizer deal gets approval from Australia's anti-trust watchdog Reuters
(Reuters) - GlaxoSmithKline's deal to buy Pfizer's consumer healthcare business will not lesson competition in Australia, the country's anti-trust regulator said on ...
Pfizer Inc. (NYSE:PFE) Return on Invested Capital at 0.417265; A Look into the Quant Driscoll Register
The Earnings to Price yield of Pfizer Inc. (NYSE:PFE) is 0.049306. This is calculated by taking the earnings per share and dividing it by the last closing share ...
The Zacks Analyst Blog Highlights: Merck, Pfizer, AbbVie, Sanofi and Glaxo Yahoo Finance
For Immediate Release. Chicago, IL ? May 6, 2019 ? Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research ...
Pfizer Receives Positive CHMP Opinion for TALZENNA® (talazoparib) for Patients with Inherited (Germline) BRCA-Mutated Locally Advanced or Metastatic Breast Cancer Yahoo Finance
Pfizer Inc. (PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a ...
Stocks to Watch: Alphabet, McDonald?s, General Electric, Gardner Denver, Pfizer, Mastercard, Western Digital, MGM Resorts, ConocoPhillips The Wall Street Journal
Companies with shares expected to trade actively in Tuesday's session include Alphabet, Western Digital, MGM Resorts International and GE.
Celgene (CELG) Holder Private Advisor Group Boosted Its Holding by $1.66 Million as Market Value Rose; As Pfizer (PFE) Stock Declined, Winslow Evans & Crocker Lifted by $822,246 Its Holding The EN Herald
Private Advisor Group Llc increased its stake in Celgene Corp (CELG) by 25.54% based on its latest 2018Q4 regulatory filing with the SEC. Private Advisor ...
Tom Miller, Iowa's attorney general, joins multi-state lawsuit against Teva, Pfizer over inflated drug prices Des Moines Register
It's unclear whether the lawsuit would be affected by a bill that would limit the attorney general's power to join out-of-state cases.
10 things to know ahead of Pfizer's earnings report New York Business Journal
The report comes just days after shareholders met and celebrated the success that the New York-based pharmaceutical giant.
Pfizer Joins Pharmaceutical Blockchain Platform MediLedger Business Blockchain HQ
Pfizer announced that it is partnering with blockchain startup Chronicled to join MediLedger, a blockchain platform to streamline drug supply chain.
Pfizer' Talzenna leads latest CHMP highlights PharmaTimes
Thirteen medicines were recommended for approval at the committee's April 2019 meeting. - News - PharmaTimes.
Fidelity Natl Information Sv (FIS) Holder Sadoff Investment Management Has Increased Its Stake by $301,308; Pfizer (PFE) Shareholder Stanley-Laman Group LTD Lowered Holding as Stock Declined The EN Herald
Sadoff Investment Management Llc increased its stake in Fidelity Natl Information Sv (FIS) by 142.16% based on its latest 2018Q4 regulatory filing with the ...
Pfizer, McKesson, AmerisourceBergen join MediLedger pharma contracting blockchain group Ledger Insights
In November the U.S. DSCSA legislation comes into force requiring returned pharmaceuticals to be verified. MediLedger offers one of the most popular DSCSA ...
Big Day for Q1 Earnings: MCD, PFE, GE & More Zacks.com
After today's close, we will hear from Apple Inc. (AAPL). This morning, here are a few of the big names reporting.
Pfizer (PFE) Announces EC Approves LORVIQUA for Certain Adult Patients with Previously-Treated ALK-Positive Advanced NSCLC StreetInsider.com
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Pfizer Oncology to Showcase New Data from Innovative Science That Address Patient Needs at ASCO 2019 Annual Meeting Yahoo Finance
NEW YORK--(BUSINESS WIRE)--. Data spans 10 therapies across 10 types of cancer. Pfizer Inc. (PFE) will present data across its industry-leading oncology ...
Eastman Chem Co (EMN) Holder Nli International Has Increased Position; As Pfizer (PFE) Market Value Declined, Fort Washington Investment Advisors Cut by $3.46 Million Its Position The NBO News
Nli International Inc increased its stake in Eastman Chem Co (EMN) by 31.1% based on its latest 2018Q4 regulatory filing with the SEC. Nli International Inc Fort ...
Can Pfizer get Xeljanz, Xtandi pumping while it waits for pipeline help? FiercePharma
Pfizer's Xtandi market share in nonmetastatic, castration-resistant prostate cancer is double that of competitor Erleada's, company executives said Tuesday.
Apg Asset Management Nv Position in Pfizer (PFE) Has Lifted as Stock Value Declined; Intel Corp. (INTC) Holder Opus Investment Management Trimmed Its Holding by $575,000 as Share Price Rose The EN Herald
Opus Investment Management Inc decreased its stake in Intel Corp. (INTC) by 10.05% based on its latest 2018Q4 regulatory filing with the SEC.
Mountain Pacific Investment Advisers Has Raised Its Stake in Charles Riv Labs Intl (CRL) by $334,932 as Market Value Rose; Wilbanks Smith & Thomas Asset Management Lowered Its Pfizer (PFE) Position as Valuation Declined The EN Herald
Mountain Pacific Investment Advisers Inc increased its stake in Charles Riv Labs Intl Inc (CRL) by 70.34% based on its latest 2018Q4 regulatory filing with the ...
Pfizer, Merck KGaA's latest Bavencio nod sets up 3-way kidney cancer battle FiercePharma
The FDA approved Pfizer and Merck KGaA's Bavencio in combination with Inlyta for the first-line treatment of patients with advanced kidney cancer. (Pfizer).
Health Care Sector Update for 05/24/2019: SURF, BMY, CELG, AXSM, JNJ, PFE, ABT, MRK, AMGN Nasdaq
Top Health Care Stocks: JNJ: -0.51% PFE: -0.48% ABT: Flat MRK: +0.21% AMGN: Flat Leading health care stocks were mixed pre-market Friday. Early.
Oakmont Maintains Stake in Cheniere Energy (LNG); As Pfizer (PFE) Stock Value Declined, Verity Asset Management Has Raised Position by $1.06 Million CryptoCoinsTribune
Oakmont Corp increased its stake in Cheniere Energy Inc (LNG) by 34.14% based on its latest 2018Q4 regulatory filing with the SEC. Oakmont Corp bought ...
Pfizer (PFE) Holder Continental Advisors Cut Its Position by $430,000 as Stock Declined; Bank Of America (BAC) Share Price Rose While Pinnacle Holdings Trimmed Holding by $9.86 Million CryptoCoinsTribune
Continental Advisors Llc decreased its stake in Pfizer Inc (PFE) by 5.36% based on its latest 2018Q4 regulatory filing with the SEC. Continental Advisors Llc ...
Verity Asset Management Upped Pfizer (PFE) Position by $1.06 Million; Shares Declined; As Nextera Energy (NEE) Stock Rose, Shareholder Mark Sheptoff Financial Planning Has Increased Its Position CryptoCoinsTribune
Verity Asset Management Inc increased its stake in Pfizer Inc (PFE) by 134.55% based on its latest 2018Q4 regulatory filing with the SEC. Verity Asset Mark ...
Yhb Investment Advisors Raised Its Pfizer (PFE) Holding by $672,649; Argent Capital Management Position in Wintrust Financial (WTFC) Has Lowered by $494,868 as Stock Price Declined CryptoCoinsTribune
Yhb Investment Advisors Inc increased its stake in Pfizer Inc (PFE) by 13.36% based on its latest 2018Q4 regulatory filing with the SEC. Yhb Investment Argent ...
BRIEF-Verily Forms Strategic Alliances With Novartis, Otsuka, Pfizer And Sanofi To Transform Clinical Research Reuters
May 21 (Reuters) - Verily, Novartis, Otsuka, Pfizer And Sanofi: * VERILY FORMS STRATEGIC ALLIANCES WITH NOVARTIS, OTSUKA, PFIZER AND SANOFI ...